Correction to: British Journal of Cancer (2010) 103: 668–675. doi:10.1038/sj.bjc.6605736
Upon publication of the above paper in Volume 103, Issue 5, the authors noticed an error in Table 1, wherein some of the totals in the final column were incorrect.
The correct Table 1 is as shown here.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6605736
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Dawson, SJ., Makretsov, N., Blows, F. et al. Erratum: BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 103, 1137 (2010). https://doi.org/10.1038/sj.bjc.6605921
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605921
